Neointima

From WikiMD's WELLNESSPEDIA

Neointima

The term neointima refers to the new tissue that forms on the inner surface of a blood vessel following an injury or surgical intervention, such as angioplasty or stent placement. This process is a part of the body's natural healing response but can lead to complications such as restenosis, where the vessel becomes narrowed again due to excessive tissue growth.

Formation of Neointima[edit]

Neointima formation is a complex biological process that involves several stages:

Endothelial Injury[edit]

The process begins with injury to the endothelial cells lining the blood vessel. This can occur due to mechanical damage from procedures like balloon angioplasty or stent deployment.

Inflammatory Response[edit]

Following endothelial injury, an inflammatory response is triggered. This involves the recruitment of inflammatory cells such as macrophages and lymphocytes to the site of injury. These cells release cytokines and growth factors that promote healing.

Smooth Muscle Cell Proliferation[edit]

One of the key events in neointima formation is the proliferation and migration of vascular smooth muscle cells (VSMCs) from the media layer of the vessel wall to the intima. These cells contribute to the thickening of the vessel wall.

Extracellular Matrix Production[edit]

VSMCs and other cells produce extracellular matrix components, such as collagen and elastin, which provide structural support to the newly formed tissue.

Clinical Implications[edit]

Neointima formation is a double-edged sword. While it is essential for healing, excessive neointimal hyperplasia can lead to restenosis, which is the re-narrowing of the blood vessel. This is a significant concern in patients who have undergone procedures to open blocked arteries, such as coronary artery stenting.

Restenosis[edit]

Restenosis is a major limitation of percutaneous coronary interventions. It occurs in a significant percentage of patients and often requires repeat procedures. Drug-eluting stents and other pharmacological strategies have been developed to mitigate this risk by inhibiting VSMC proliferation and neointimal hyperplasia.

Research and Developments[edit]

Ongoing research is focused on understanding the molecular mechanisms underlying neointima formation and developing new therapies to prevent restenosis. This includes the study of gene expression changes, signaling pathways, and the role of specific cytokines and growth factors.

Also see[edit]

Stub icon

This medical article is a stub. You can help WikiMD by expanding the page.


Cardiovascular disease A-Z

Most common cardiac diseases

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

A[edit]

B[edit]

C[edit]

D[edit]

E[edit]

H[edit]

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

I[edit]

K[edit]

L[edit]

M[edit]

N[edit]

O[edit]

P[edit]

R[edit]

S[edit]

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

T[edit]

V[edit]

W[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Neointima&oldid=6525213"